BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PLoS One. 2020;15:e0241541. [PMID: 33206661 DOI: 10.1371/journal.pone.0241541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Reference Citation Analysis]
2 Kondakov A, Berdalin A, Lelyuk V, Gubskiy I, Golovin D. Risk Factors of In-Hospital Mortality in Non-Specialized Tertiary Center Repurposed for Medical Care to COVID-19 Patients in Russia. Diagnostics (Basel) 2021;11:1687. [PMID: 34574028 DOI: 10.3390/diagnostics11091687] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wali B, Frank LD. Neighborhood-level COVID-19 hospitalizations and mortality relationships with built environment, active and sedentary travel. Health Place 2021;71:102659. [PMID: 34481153 DOI: 10.1016/j.healthplace.2021.102659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu A, Patel A, Pierce A, Fowler R. Variations in Presentation and Management of COVID-19 Inpatients by Race and Ethnicity in a Large Texas Metroplex. Disaster Med Public Health Prep 2021;:1-10. [PMID: 34247684 DOI: 10.1017/dmp.2021.224] [Reference Citation Analysis]
5 Maguire D, Richards C, Woods M, Dolan R, Wilson Veitch J, Sim WMJ, Kemmett OEH, Milton DC, Randall SLW, Bui LD, Goldmann N, Brown A, Gillen E, Cameron A, Laird B, Talwar D, Godber IM, Wadsworth J, Catchpole A, Davidson A, McMillan DC. The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts. PLoS One 2021;16:e0251924. [PMID: 34043668 DOI: 10.1371/journal.pone.0251924] [Reference Citation Analysis]
6 Crispi F, Crovetto F, Larroya M, Camacho M, Tortajada M, Sibila O, Badia JR, López M, Vellvé K, Garcia F, Trilla A, Faner R, Blanco I, Borràs R, Agustí A, Gratacós E. Low birth weight as a potential risk factor for severe COVID-19 in adults. Sci Rep 2021;11:2909. [PMID: 33536488 DOI: 10.1038/s41598-021-82389-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fishchuk L, Rossokha Z, Pokhylko V, Cherniavska Y, Tsvirenko S, Kovtun S, Medvedieva N, Vershyhora V, Gorovenko N. Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study. Drug Metab Pers Ther 2021. [PMID: 34860474 DOI: 10.1515/dmpt-2021-0127] [Reference Citation Analysis]
8 Seoane B. A scaling approach to estimate the age-dependent COVID-19 infection fatality ratio from incomplete data. PLoS One 2021;16:e0246831. [PMID: 33596249 DOI: 10.1371/journal.pone.0246831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Stamm P, Sagoschen I, Weise K, Plachter B, Münzel T, Gori T, Vosseler M. Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing. Med Microbiol Immunol 2021;210:277-82. [PMID: 34604931 DOI: 10.1007/s00430-021-00720-7] [Reference Citation Analysis]
10 Dao TL, Hoang VT, Colson P, Lagier JC, Million M, Raoult D, Levasseur A, Gautret P. SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence. J Clin Med 2021;10:2635. [PMID: 34203844 DOI: 10.3390/jcm10122635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM; BLAZE-1 Investigators. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. N Engl J Med 2021. [PMID: 34260849 DOI: 10.1056/NEJMoa2102685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
12 Agrawal A, Jha T, Gogoi P, Diwaker P, Goel A, Khan AM, Saxena AK. Effect of Convalescent Plasma therapy on Mortality in Moderate-to-Severely Ill COVID-19 Patients. Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103455] [Reference Citation Analysis]
13 Martínez-Vega RA, Jing W, Ortega-Villa AM, Delgado-Cuellar OM, Hernández-Hernández VA, Jan-Gómez JC, Rincón-León HA, Constantino-Santiesteban P, García-Guerra MP, Cetina-Díaz JH, Pérez-Tirado JM, Gómez-Cruz O, Amaya-Larios IY, Ramos-Castañeda J, Jesús SD. Risk Prediction of Death in Inpatient Adults With COVID-19 from Mexico. Res Sq 2021:rs. [PMID: 34751267 DOI: 10.21203/rs.3.rs-996535/v1] [Reference Citation Analysis]
14 Voncken SFJ, Feron TMH, Laven SAJS, Karaca U, Beerhorst K, Klarenbeek P, Straetmans JMJAA, de Vries GJ, Kolfoort-Otte AAB, de Kruif MD. Impact of obstructive sleep apnea on clinical outcomes in patients hospitalized with COVID-19. Sleep Breath 2021. [PMID: 34561757 DOI: 10.1007/s11325-021-02476-z] [Reference Citation Analysis]
15 Arshad S, Albayat SS, Arshad MA, Jabbar A, Ullah I. Compliance of hand hygiene can play a pivotal role in limiting the spread of COVID-19 through public transportation. Public Health Pract (Oxf) 2021;2:100216. [PMID: 34751260 DOI: 10.1016/j.puhip.2021.100216] [Reference Citation Analysis]
16 Gogolewski K, Miasojedow B, Sadkowska-todys M, Stepień M, Demkow U, Lech A, Szczurek E, Rabczenko D, Rosińska M, Gambin A. Data-driven case fatality rate estimation for the primary lineage of SARS-CoV-2 in Poland. Methods 2022. [DOI: 10.1016/j.ymeth.2022.01.006] [Reference Citation Analysis]
17 Mann CZ, Abshire C, Yost M, Kaatz S, Swaminathan L, Flanders SA, Prescott HC, Gagnon-Bartsch JA. Derivation and external validation of a simple risk score to predict in-hospital mortality in patients hospitalized for COVID-19: A multicenter retrospective cohort study. Medicine (Baltimore) 2021;100:e27422. [PMID: 34622851 DOI: 10.1097/MD.0000000000027422] [Reference Citation Analysis]
18 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
19 Martinez-Guerra BA, Gonzalez-Lara MF, Roman-Montes CM, Tamez-Torres KM, Dardón-Fierro FE, Rajme-Lopez S, Medrano-Borromeo C, Martínez-Valenzuela A, Ortiz-Brizuela E, Sifuentes-Osornio J, Ponce-de-Leon A. Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study. Emerg Microbes Infect 2022;11:50-9. [PMID: 34839785 DOI: 10.1080/22221751.2021.2011619] [Reference Citation Analysis]
20 Jassat W, Cohen C, Tempia S, Masha M, Goldstein S, Kufa T, Murangandi P, Savulescu D, Walaza S, Bam JL, Davies MA, Prozesky HW, Naude J, Mnguni AT, Lawrence CA, Mathema HT, Zamparini J, Black J, Mehta R, Parker A, Chikobvu P, Dawood H, Muvhango N, Strydom R, Adelekan T, Mdlovu B, Moodley N, Namavhandu EL, Rheeder P, Venturas J, Magula N, Blumberg L; DATCOV author group. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV 2021:S2352-3018(21)00151-X. [PMID: 34363789 DOI: 10.1016/S2352-3018(21)00151-X] [Reference Citation Analysis]
21 Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, Krishna A, Jagiasi BG, Juneja D, Barthakur HS, Jha H, Gurjar M, Rangappa P, Aladakatti R, Mishra RC, Shetty RM, Yadav R, Garg S, Nandakumar SM, Samavedam S, Ray S, Hadda V, Javeri Y, Munjal M. Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19. Indian J Crit Care Med 2021;25:1280-5. [PMID: 34866826 DOI: 10.5005/jp-journals-10071-23923] [Reference Citation Analysis]
22 Gentilini F, Turba ME, Taddei F, Gritti T, Fantini M, Dirani G, Sambri V. Modelling RT-qPCR cycle-threshold using digital PCR data for implementing SARS-CoV-2 viral load studies. PLoS One 2021;16:e0260884. [PMID: 34928966 DOI: 10.1371/journal.pone.0260884] [Reference Citation Analysis]
23 Malhotra V, Basu S, Sharma N, Kumar S, Garg S, Dushyant K, Borle A. Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India. J Med Virol 2021;93:4553-8. [PMID: 33755238 DOI: 10.1002/jmv.26956] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zhou L, Ayeh SK, Chidambaram V, Karakousis PC. Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions. BMC Infect Dis 2021;21:496. [PMID: 34049515 DOI: 10.1186/s12879-021-06222-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Najm A, Alunno A, Mariette X, Terrier B, De Marco G, Emmel J, Mason L, McGonagle DG, Machado PM. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider. RMD Open 2021;7:e001549. [PMID: 33574116 DOI: 10.1136/rmdopen-2020-001549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Garcia-gutiérrez S, Esteban-aizpiri C, Lafuente I, Barrio I, Quiros R, Quintana JM, Uranga A, García-gutiérrez S, Lafuente I, Quintana JM, Orive M, Gonzalez N, Anton A, Villanueva A, Muñoz C, Legarreta MJ, Quirós R, Yandiola PPE, Egurrola M, Aramburu A, Artaraz A, Chasco L, Bronte O, García P, Jodar A, Fernandez V, Esteban C, Mas N, Pulido E, Bengoetxea I, Martínez AE, Bilbao A, Gorostiza I, Arriaga I, Zapiarain JJP, Parraza N, Iriberri M, Zalacain R, Ruiz LA, Serrano L, Couto A, Ateka O, Cano A, Ibarra MO, Millan E, Bacigalupe M, Letona J, Arcelay A, Berraondo I, Castells X, Posso M, Perestelo L, Acosta GP, Gonzñalez CM, Redondo M, Padilla M, Muñoz A, de Madariaga RS; COVID-REDISSEC Working Group. Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09771-z] [Reference Citation Analysis]
27 Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F; COVIDSER study group. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD Open 2021;7:e001925. [PMID: 34887346 DOI: 10.1136/rmdopen-2021-001925] [Reference Citation Analysis]
28 Markovic S, Rodic A, Salom I, Milicevic O, Djordjevic M, Djordjevic M. COVID-19 severity determinants inferred through ecological and epidemiological modeling. One Health 2021;13:100355. [PMID: 34869819 DOI: 10.1016/j.onehlt.2021.100355] [Reference Citation Analysis]
29 Ayeh SK, Abbey EJ, Khalifa BAA, Nudotor RD, Osei AD, Chidambaram V, Osuji N, Khan S, Salia EL, Oduwole MO, Yusuf HE, Lasisi O, Nosakhare E, Karakousis PC. Statins use and COVID-19 outcomes in hospitalized patients. PLoS One 2021;16:e0256899. [PMID: 34506533 DOI: 10.1371/journal.pone.0256899] [Reference Citation Analysis]
30 Chidambaram V, Tun NL, Majella MG, Ruelas Castillo J, Ayeh SK, Kumar A, Neupane P, Sivakumar RK, Win EP, Abbey EJ, Wang S, Zimmerman A, Blanck J, Gupte A, Wang JY, Karakousis PC. Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: A retrospective cohort study, a systematic review of the literature, and meta-analysis. Clin Infect Dis 2021:ciab527. [PMID: 34100919 DOI: 10.1093/cid/ciab527] [Reference Citation Analysis]
31 Heinert SW, Riggs R, Prendergast H. Emergency Department Management of Hypertension in the Context of COVID-19. Curr Hypertens Rep. [DOI: 10.1007/s11906-022-01169-6] [Reference Citation Analysis]
32 Ozdemir C, Durmaz A, Akbas Gunes N. Epidemiological Characteristics of COVID-19 Patients in Kütahya Province in Turkey. Euras J Fam Med 2021;10:135-40. [DOI: 10.33880/ejfm.2021100304] [Reference Citation Analysis]
33 Ji H, Dai Q, Jin H, Xu K, Ai J, Fang X, Shi N, Huang H, Wu Y, Peng Z, Hu J, Zhu L, Bao C, Wu M. Epidemiology of 631 Cases of COVID-19 Identified in Jiangsu Province Between January 1st and March 20th 2020: Factors Associated with Disease Severity and Analysis of Zero Mortality. Med Sci Monit 2021;27:e929986. [PMID: 33863868 DOI: 10.12659/MSM.929986] [Reference Citation Analysis]
34 Al-Saadi EAKD, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal 2021;:e24064. [PMID: 34783405 DOI: 10.1002/jcla.24064] [Reference Citation Analysis]
35 Abbattista M, Ciavarella A, Capecchi M, Tantardini F, Gramegna A, Lombardi R, Scaramellini N, Peyvandi F, Martinelli I. Risk factors for mortality in hospitalized patients with COVID-19: a study in Milan, Italy. Infectious Diseases 2021;53:226-9. [DOI: 10.1080/23744235.2020.1859131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis. PLoS One 2021;16:e0259006. [PMID: 34673822 DOI: 10.1371/journal.pone.0259006] [Reference Citation Analysis]
37 Rutten JJS, van Kooten J, van Loon AM, van Buul LW, Joling KJ, Smalbrugge M, Hertogh CMPM. Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19. J Alzheimers Dis 2021;84:1173-81. [PMID: 34542068 DOI: 10.3233/JAD-210319] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ryrsø CK, Dungu AM, Hegelund MH, Jensen AV, Sejdic A, Faurholt-Jepsen D, Krogh-Madsen R, Lindegaard B. Body composition, physical capacity, and immuno-metabolic profile in community-acquired pneumonia caused by COVID-19, influenza, and bacteria: a prospective cohort study. Int J Obes (Lond) 2022. [PMID: 34987205 DOI: 10.1038/s41366-021-01057-0] [Reference Citation Analysis]
39 Frank LD, Wali B. Treating two pandemics for the price of one: Chronic and infectious disease impacts of the built and natural environment. Sustain Cities Soc 2021;73:103089. [PMID: 34155475 DOI: 10.1016/j.scs.2021.103089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chekuri S, Szymczak WA, Goldstein DY, Nori P, Marrero Rolon R, Spund B, Singh-Tan S, Mohrmann L, Assa A, Southern WN, Baron SW. SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study. J Antimicrob Chemother 2021;76:iii12-9. [PMID: 34555160 DOI: 10.1093/jac/dkab244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Fröberg J, Diavatopoulos DA. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Infect Dis 2021;34:181-6. [PMID: 33899752 DOI: 10.1097/QCO.0000000000000724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Naeini MB, Sahebi M, Nikbakht F, Jamshidi Z, Ahmadimanesh M, Hashemi M, Ramezani J, Miri HH, Yazdian-Robati R. A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19. Obes Med 2021;22:100323. [PMID: 33521379 DOI: 10.1016/j.obmed.2021.100323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
43 Gassen J, Nowak TJ, Henderson AD, Weaver SP, Baker EJ, Muehlenbein MP. Unrealistic Optimism and Risk for COVID-19 Disease. Front Psychol 2021;12:647461. [PMID: 34149531 DOI: 10.3389/fpsyg.2021.647461] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Diaz-Arocutipa C, Carvallo-Castañeda D, Luis-Ybañez O, Pariona M, Rivas-Lasarte M, Álvarez-García J. COVID-19 in heart transplant recipients during February-August 2020: A systematic review. Clin Transplant 2021. [PMID: 34159650 DOI: 10.1111/ctr.14390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Singh S, Verma N, Kanaujia R, Chakrabarti A, Rudramurthy SM. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses 2021;64:1015-27. [PMID: 34057252 DOI: 10.1111/myc.13328] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Lee PN, Hamling JS, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in Europe, Israel, America and Australasia on smoking and COVID-19. World J Meta-Anal 2021; 9(4): 353-376 [DOI: 10.13105/wjma.v9.i4.353] [Reference Citation Analysis]
47 Hyun M, Lee JY, Park JS, Kim JY, Kim HA. Comparison of the Characteristics of Asymptomatic and Presymptomatic Patients with Coronavirus Disease 2019 in the Republic of Korea. J Epidemiol Glob Health 2021. [PMID: 34757529 DOI: 10.1007/s44197-021-00011-7] [Reference Citation Analysis]
48 Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, Koch J, Nygren T, Scholz S, Schönfeld V, Vygen-Bonnet S, Wichmann O, Harder T. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med 2021;19:212. [PMID: 34446016 DOI: 10.1186/s12916-021-02058-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
49 John KJ, Mishra AK, Ramasamy C, George AA, Selvaraj V, Lal A. Heart failure in COVID-19 patients: Critical care experience. World J Virol 2022; 11(1): 1-19 [DOI: 10.5501/wjv.v11.i1.1] [Reference Citation Analysis]
50 Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, Krishna A, Jagiasi BG, Juneja D, Barthakur HS, Jha H, Gurjar M, Rangappa P, Aladakatti R, Mishra RC, Shetty RM, Yadav R, Garg S, Nandakumar SM, Samavedam S, Ray S, Hadda V, Javeri Y, Munjal M. Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19. Indian J Crit Care Med 2021;25:1280-5. [PMID: 34866826 DOI: 10.5005/jp-journals-10071-23923] [Reference Citation Analysis]
51 Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity . World J Diabetes 2021; 12(9): 1550-1562 [PMID: 34630907 DOI: 10.4239/wjd.v12.i9.1550] [Reference Citation Analysis]
52 Burslem R, Parker A. Medical nutrition therapy for patients with malnutrition post-intensive care unit discharge: A case report of recovery from coronavirus disease 2019 (COVID-19). Nutr Clin Pract 2021;36:820-7. [PMID: 34245599 DOI: 10.1002/ncp.10728] [Reference Citation Analysis]
53 Lau JFW, Woon YL, Leong CT, Teh HS. Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey. Osong Public Health Res Perspect 2021;12:361-73. [PMID: 34818501 DOI: 10.24171/j.phrp.2021.0085] [Reference Citation Analysis]
54 Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID-19 and chronic kidney disease: an updated overview of reviews. J Nephrol 2022. [PMID: 35013985 DOI: 10.1007/s40620-021-01206-8] [Reference Citation Analysis]
55 Shindo Y, Kondoh Y, Kada A, Doi Y, Tomii K, Mukae H, Murata N, Imai R, Okamoto M, Yamano Y, Miyazaki Y, Shinoda M, Aso H, Izumi S, Ishii H, Ito R, Saito AM, Saito TI, Hasegawa Y. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure. Infect Dis Ther 2021. [PMID: 34368914 DOI: 10.1007/s40121-021-00512-9] [Reference Citation Analysis]
56 Kokturk N, Babayigit C, Kul S, Duru Cetinkaya P, Atis Nayci S, Argun Baris S, Karcioglu O, Aysert P, Irmak I, Akbas Yuksel A, Sekibag Y, Baydar Toprak O, Azak E, Mulamahmutoglu S, Cuhadaroglu C, Demirel A, Kerget B, Baran Ketencioglu B, Ozger HS, Ozkan G, Ture Z, Ergan B, Avkan Oguz V, Kilinc O, Ercelik M, Ulukavak Ciftci T, Alici O, Nurlu Temel E, Ataoglu O, Aydin A, Cetiner Bahcetepe D, Gullu YT, Fakili F, Deveci F, Kose N, Tor MM, Gunluoglu G, Altin S, Turgut T, Tuna T, Ozturk O, Dikensoy O, Yildiz Gulhan P, Basyigit I, Boyaci H, Oguzulgen IK, Borekci S, Gemicioglu B, Bayraktar F, Elbek O, Hanta I, Kuzu Okur H, Sagcan G, Uzun O, Akgun M, Altinisik G, Dursun B, Cakir Edis E, Gulhan E, Oner Eyuboglu F, Gultekin O, Havlucu Y, Ozkan M, Sakar Coskun A, Sayiner A, Kalyoncu AF, Itil O, Bayram H. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med 2021;183:106433. [PMID: 33957434 DOI: 10.1016/j.rmed.2021.106433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
57 Chidambaram V, Shanmugavel Geetha H, Kumar A, Majella MG, Sivakumar RK, Voruganti D, Mehta JL, Karakousis PC. Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2022;9:862999. [DOI: 10.3389/fcvm.2022.862999] [Reference Citation Analysis]